Hemab Therapeutics Holdings, Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-24. Between them they name 2 people, with 2 appointments and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Keli Walbert, Director
On September 24, 2026, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Hemab Therapeutics Holdings, Inc. (the "Company"), the Board elected Keli Walbert to serve as a member of the Board, effective immediately.
Appointed: Keli Walbert
The Board also elected Ms. Walbert to serve as a member of the Audit Committee of the Board (the "Audit Committee").
Departing: Laura Tadvalkar, Director
On May 8, 2026, Laura Tadvalkar, Ph.D., notified Hemab Therapeutics Holdings, Inc. (the "Company") of her decision to resign as a member of the Company's board of directors (the "Board"), effective immediately.
Find people with the same kind of experience as the Director at Hemab Therapeutics Holdings, Inc., with the record behind each one.
Find candidates like Director at Hemab Therapeutics Holdings, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Hemab Therapeutics Holdings, Inc. is in the news or changes leadership.
Get an alert when Hemab Therapeutics Holdings, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Hemab Therapeutics Holdings, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.